Literature DB >> 9562182

Increased axon growth through astrocyte cell lines transfected with urokinase.

E Muir1, J S Du, J Fok-Seang, L C Smith-Thomas, E S Housden, J Rogers, J W Fawcett.   

Abstract

The ability of cells to migrate through tissues depends on their production of a variety of proteases, and the same may be true of growth cones. Urokinase (plasminogen activator) regulates much of the extracellular proteolytic activity, by activating other proteases and as a result of its own proteolytic activity. In order to evaluate the potential role of urokinase as a promoter of axon growth, we have used a plasmid expressing urokinase under a cytomegalovirus promoter to transfect an astrocyte cell line, Neu7, which we have previously shown to provide a poor environment for axon regeneration. Five transfected lines all showed greatly increased ability to promote axon regeneration in both monolayer and three-dimensional cultures. The critical change in the transfected cells was largely within the extracellular matrix, since extracellular matrix laid down by urokinase-secreting cells was more permissive to axon growth than matrix from the parent Neu7 line. The effect was due to urokinase since treatment of the transfected cells with the urokinase inhibitors B623 and B428 rendered both the cells and their matrix much less permissive to axon growth, but did not require plasminogen, since it was blocked neither by serum-free medium nor by plasmin inhibitors.

Mesh:

Substances:

Year:  1998        PMID: 9562182

Source DB:  PubMed          Journal:  Glia        ISSN: 0894-1491            Impact factor:   7.452


  2 in total

1.  Gene delivery to overcome astrocyte inhibition of axonal growth: an in vitro model of the glial scar.

Authors:  Hannah M Tuinstra; Melissa M Ducommun; William E Briley; Lonnie D Shea
Journal:  Biotechnol Bioeng       Date:  2012-11-01       Impact factor: 4.530

2.  Mechanism of plasminogen activator inhibitor-1 regulation by oncostatin M and interleukin-1 in human astrocytes.

Authors:  Aneta Kasza; Daniel L Kiss; Sunita Gopalan; Weili Xu; Russell E Rydel; Aleksander Koj; Tomasz Kordula
Journal:  J Neurochem       Date:  2002-11       Impact factor: 5.372

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.